|Baxter Declares Quarterly Dividend|
|View printer-friendly version|
Baxter provides a broad portfolio of essential renal and hospital products, including home, acute and in-center dialysis; sterile IV solutions; infusion systems and devices; parenteral nutrition; surgery products and anesthetics; and pharmacy automation, software and services. The company’s global footprint and the critical nature of its products and services play a key role in expanding access to healthcare in emerging and developed countries. Baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations that enable patient care.
This release includes forward-looking statements concerning Baxter's
dividend. The statements are based on assumptions about many important
factors, including the following, which could cause actual results to
differ materially from those in the forward-looking statements:
continued strength in the company’s financial position, including cash
flows; future decisions of the board of directors of the company to
continue payments to shareholders in the form of a dividend on a
quarterly or other basis relative to alternative uses of funds; and
other risks identified in the company's most recent filing on Form 10-K
Baxter International Inc.